NCT05090956

Brief Summary

Since January 2010, a new magnetic resonance imaging scanner (Philips 3T, Achieva) is installed on the Baudot Building in Toulouse hospital. This tool, is completely dedicated to the research. It was installed with sequences RMN supplied by the manufacturer. Imagers also contain an instrumentation susceptible to evolution and/or to adjustment (antennas radio frequency, sheath of gradients, elements of physiological monitoring (for example control of the breath), regulation of the homogeneity of the magnetic field). This MRI scanner and this instrumentation are used for anatomical examinations or for paradigms of cognitiveresearch (for example of detection of intellectual activations following simple stimuli of fingers movement, visual tasks, or of mental processes). The developpement of this equipment is going to favor the emergence of numerous projects and new themes, up to there adressed by other techniques (psychophysics, EEG). To obtain good quality signals and know the practical limits of this imager, it is thus necessary that the researchers doctors, physicists and engineers, can finalize on volunteers' significant number, all the sequences RMN necessary for the use of these tools for the research. These developments are going to get organized around four main axes: 1 the control of the geometrical distortions (generated by the introduction of an object within the magnetic field) 2 Optimization of the parameters of sequences to improve the contrast and the spatial resolution of the obtained images 3 the development of new sequences 4 the feasibility study of the protocols of functional MRI

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
230

participants targeted

Target at P75+ for not_applicable healthy

Timeline
Completed

Started Jun 2012

Longer than P75 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 8, 2012

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 7, 2012

Completed
7.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 29, 2020

Completed
1.7 years until next milestone

First Posted

Study publicly available on registry

October 25, 2021

Completed
Last Updated

October 25, 2021

Status Verified

October 1, 2021

Enrollment Period

7.6 years

First QC Date

September 7, 2012

Last Update Submit

October 11, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • quality of MRI images

    assessment of distortion of MRI images

    90 months

Study Arms (1)

control

EXPERIMENTAL

MRI exam; The sequences to be performed will be presented to the subject according to the focus to be performed. maximal duration of the exam: 2 hours (including subject set up)

Other: mri

Interventions

mriOTHER
control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy adult, age = 18 years;
  • Visual, hearing , oral or written capacities and expression sufficient for the suitable realization of the tests;
  • Obtaining of the informed consent of the subject.

You may not qualify if:

  • Subjects presenting a neurological, psychiatric history;
  • Subjects under chronic medication which can influence the intellectual activity;
  • Subjects presenting a contraindication to the MRI (carriers of a pacemaker, an implanted material(equipment) activated by an electric, magnetic or mechanical system, carriers of haemostatic clips of anévrysmes intracérébraux or carotid arteries, carriers of orthopaedic, claustrophobic implants);
  • Subjects refusing to be informed about the possible presence of an anatomical anormality;
  • administrative Problems: impossibility to give about the information, no insurance, refusal to sign the consent, under guardianship subject ;
  • Subjects participating in another protocol • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Inserm U825

Toulouse, France

Location

MeSH Terms

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Interventions

Magnetic Resonance Spectroscopy

Condition Hierarchy (Ancestors)

Leukemia, LymphoidLeukemiaNeoplasms by Histologic TypeNeoplasmsHematologic DiseasesHemic and Lymphatic DiseasesLymphoproliferative DisordersLymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 7, 2012

First Posted

October 25, 2021

Study Start

June 8, 2012

Primary Completion

January 1, 2020

Study Completion

January 29, 2020

Last Updated

October 25, 2021

Record last verified: 2021-10

Locations